Panel Discussion | Prevalence Impact and Management of HALT and Valve Thrombosis

Monday, March 10, 2025

2:17 PM - 2:38 PM ET

Panel Moderator(s)

Hasan A. Jilaihawi, MD

Professor
Cedars-Sinai Medical Center
Los Angeles, California, United States

Disclosure information not submitted.
Jaffar M. Khan, MD, PhD

Director of Cardiovascular Innovation and Director of Interventional Electrosurgery
St Francis Hospital and Heart Center
Roslyn, New York, United States

No relationships to disclose
Konstantinos Marmagkiolis, MD,MBA,FACC,FSCAI

interventional, structural, and endovascular cardiologist
Heart and Vascular Institute (HVI) at Tampa General Hospital (TGH) in Tampa, FL
Wesley Chapel, Florida, United States

No relationships to disclose

Panel Discussant(s)

Wah Wah Htun, MD

Chief of Cardiology
Gundersen Health
La crosse , Wisconsin, United States

No relationships to disclose
Toby Rogers, MD, PhD

Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure information not submitted.
Jolanta M. Siller-Matula, MD PhD

Associate Professor
Medical University of Vienna, Department of Cardiology
Vienna, AUSTRIA, Wien, Austria

Disclosure(s): AOP: Grant/Research Support (Terminated); Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)
Stephanie Sellers, PhD

Assistant Professor
University of British Columbia
Vancouver, British Columbia, Canada

No relationships to disclose

Panel Moderator(s)

Poonam Velagapudi, MD

Structural and Interventional Cardiologist
BJC Cardiology
Demarest, New Jersey, United States

No relationships to disclose

Disclosure(s):

Jaffar M. Khan, MD, PhD: Abbott, Edwards Lifesciences, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Cuspa medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Transmural Systems, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Konstantinos Marmagkiolis, MD,MBA,FACC,FSCAI: No financial relationships to disclose

Wah Wah Htun, MD: No financial relationships to disclose

Toby Rogers, MD, PhD: Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)

Jolanta M. Siller-Matula, MD PhD: AOP: Grant/Research Support (Terminated); Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

Stephanie Sellers, PhD: Abbott: Consultant (Ongoing); Anteris: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Excision Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock options (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Vivitro Labs: Grant/Research Support (Ongoing)

Poonam Velagapudi, MD: Medtronic: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)